*
Biosimilars: What we can learn from early adopters
Download the white paper
Despite growing interest in biosimilars, many oncology practices still face challenges with adopting them. Sonia Oskouei, Vice President of Biosimilars at Cardinal Health, recently sat down with leaders at three oncology practices that were early biosimilar adopters to discuss how they overcame common challenges and the lessons they learned along the way. Based on their experiences and perspectives, we outlined a series of best practices in this white paper to help any oncology practice navigate the changing biosimilar landscape.
*
I would like to discuss my biosimilar strategy with a Cardinal Health consultant.
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.